Back to Agenda
[V5-S2] How to Provide Drug Information from a Standpoint of a Patient (Part 1)
Session Chair(s)
Yuko Kojima, RPh
Sr. Executive Director
Eli Lilly Japan K.K., Japan
Mamoru Narukawa, PhD, RPh
Professor
Kitasato University, Japan
Speaker(s)
The Regulations of Drug Information Provision and its Challenges - From the Regulatory Agencies' Perspective
Tomoko Tanita
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Risk Communication Promotion Division, Office of Safety I
The Current Status and the Issue of Drug Information Provision from the Pharmaceutical Industry Perspective
Junichi Nishino, MSc, RPh
Otsuka Pharmaceutical Co., Ltd., Japan
Head, Regulatory Affairs Department
The Current Status of the Providing Drug Information and Issue of the Medical Communication - The Point of View from Medical Site
Masahiro Hayashi, PhD
Toranomon Hospital, Japan
Pharmaceutical affairs specialist, Department of Pharmacy
Have an account?